Role and optimal dosing of angiotensin-converting enzyme inhibitor therapy.
Kazi
Dhruv
D
Baylor College of Medicine, Houston, TX 77030, USA.
Deswal
Anita
A
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D044383:Black People; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004341:Drug Evaluation; D005260:Female; D006333:Heart Failure / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000150:complications; D018579:Patient Selection; D012084:Renin-Angiotensin System / Q000187:drug effects; D012737:Sex Factors; D016896:Treatment Outcome; D018487:Ventricular Dysfunction, Left / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism; D044465:White People
D000806:Angiotensin-Converting Enzyme Inhibitors